Ethyl 2-(2,5-dimethylphenyl)-2,2-difluoroacetate, 5g

Silver iodide, 97%, 5g

1-Ethyl-3-methyl-1H-pyrazol-4-ylamine, 95.0%, 10g

(2R)-1-[(TERT-BUTOXY)CARBONYL]-2-PROPYLPYRROLIDINE-2-CARBOXYLIC ACID, 95%, 5g

1-Boc-4-Cbz-Aminopiperidine, 95.0%, 1g

5-Bromo-2-methylaniline, 97.0%, 25g

(5-methyl-6-oxo-1,6-dihydropyridin-3-yl)boronic acid, 95+%, 1g

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)acetamide, 97%, 100mg

(4aR,7aR)-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylate, 97%, 1g

(2-Benzothiazolylthio)acetic Acid>98.0%(HPLC)(T)500g

(4-Chloropyridine-2-yl)methanol, 95.0%, 10g

1-(tert-Butoxycarbonyl)-5-oxopyrrolidine-2-carboxylic acid, 95%, 5g

Ethyl 1-hydroxycyclopropanecarboxylate, 95.0%, 5g